About Us

Halo Labs is revolutionizing biopharmaceutical drug product quality by commercializing low volume, high throughput tools to characterize product stability and safety. From developability assessment through quality control, Halo Labs provides unprecedented insights that reduce development time and improve patient safety.

Halo’s management team is a seasoned group of life science professionals who on average have over 20 years of experience delivering solutions to the life science marketplace. Our growth strategy includes disrupting outdated analytical methods as well as addressing the challenges of the fastest growing biopharmaceutical sectors.

Our venture support comes from Agilent Technologies, Research Corporation Technologies (RCT), BioAdvance, Broad Oak Capital Partners, and Ben Franklin Technology Partners.

Halo Labs Executive Team

Interested in joining the Halo Labs team?

There are no team members to display.

Board of Directors

Dr. Joseph D. Keegan
Rick Gordon
Dr. Shahram Hejazi
Board Member
Bill Snider
Board Member
Broad Oak
Dr. Chad Souvignier
Board Member